CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-16 | ROBERTSON SANFORD Director | Gift | +5,000 | 5,000 | ||
| 2024-05-09 | GUSSIN ROBERT Z Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-09 | O DONNELL MICHAEL J Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-05-09 | Barry Richard Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-09 | ROBERTSON SANFORD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-05-09 | SCANNON PATRICK J MD PHD Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-05-09 | Anderson Robert Eugene Jr Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-05-09 | Gravier Pierre Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-05-09 | Nicaise Claude Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-04-26 | ROBERTSON SANFORD Director | Option exercise | +69,000 | $22.00 | $1.5M | 955,851 |
| 2024-04-26 | ROBERTSON SANFORD Director | Option exercise · Common Stock Warrant | −46,000 | 308,740 | ||
| 2024-04-23 | Barry Richard Director | Option exercise | +176,085 | $22.00 | $3.9M | 469,562 |
| 2024-04-23 | Barry Richard Director | Option exercise · Common Stock Warrant | −117,390 | 0 | ||
| 2024-04-18 | Kupiec James William Chief Medical Officer | Option exercise | +1,500 | $22.00 | $33K | 4,000 |
| 2024-04-18 | Kupiec James William Chief Medical Officer | Option exercise · Common Stock Warrant | −1,000 | 0 | ||
| 2024-04-17 | Schoen Eric Chief Financial Officer | Option exercise | +1,500 | $22.00 | $33K | 21,300 |
| 2024-04-17 | Schoen Eric Chief Financial Officer | Option exercise · Common Stock Warrant | −1,000 | 6,920 | ||
| 2024-01-03 | ROBERTSON SANFORD Director | Grant or award · Common Stock Warrant | +72,000 | 72,000 | ||
| 2024-01-03 | ROBERTSON SANFORD Director | Grant or award · Common Stock Warrant | +354,740 | 354,740 | ||
| 2024-01-03 | Barry Richard Director | Grant or award · Common Stock Warrant | +117,390 | 176,085 |
Page 3 of 17 · 324 trades